atepeq/tico19 huggingface dataset:
about how long have these symptoms been going on?
basymptomi oyo ewumeli mikolo boni?
and all chest pain should be treated this way especially with your age
mpe bampasi nyonso ya ntolo esengeli esalisama mpona kobika lolenge oyo mpona mibu na yo
and along with a fever
mpe elongo na fefele
and also needs to be checked your cholesterol blood pressure
mpe esengeli kotala tansio ya cholesterole na yo
and are you having a fever now?
mpe yo ozali na fefele sikoyo?
and are you having any of the following symptoms with your chest pain
mpe ozali na moko ya basymptomi oyo elandi na mpasi na yo ya tolo
and are you having a runny nose?
mpe ozali na zolo ezali kotanga miyoyo?
and are you having this chest pain now?
mpe ozali na mpasi na ntolo sikoyo?
and besides do you have difficulty breathing
mpe ozali na mpasi ya kopema
and can you tell me what other symptoms are you having along with this?
mpe okoki koyebisa ngai basymptomi misusu ozali na yango elongo na oyo?
and does this pain move from your chest?
mpe mpasi yango ya tolo ezali kotambola bisika mosusu?
and drink lots of fluids
mpe mela biloko ya maimai mingi
and how high has your fever been
mpe fefele na yo ezalaki makasi ndenge nini
and i have a cough too
mpe nazali lisusu na kosukosu
and i have a little cold and a cough
mpe nazali na malili moke na kosukosu
and i'm really having some bad chest pain today
mpe lelo nazali komona mpasi makasi na ntolo
and is this the right time for your hay fever
pe oyo tango ekoki pona fievre nayo ya foin
and it get the chest pain
mpe ekomi na ntolo
and i think i have a little bit of a fever
mpe nakanisi nazali nan fefele moke
and i want you to describe where the chest pain is
mpe nalingi yo olimbola ngai esika mpasi ya ntolo ezali
and she is sorta have the same symptoms
mpe lekola ye pe azali na basymptomi ndenge moko
and tell me what symptoms are you having now?
mpe yebisa ngai, sikoyo basymptomi nini ozali na yango?
and they're having some fevers as well
mpe bazali na fefele moke mpe
and with your history of diabetes
mpe na lisolo na yo ya diabeti
and you know it feels like my chest is like gonna crush
mpe oyebi ezali kosala lekola ntolo na ngai ekobukana
and you know people cough on me all the time
mpe oyobe bato bazali kokosola likolo na ngai bangona nyonso
and you're having chest pain
mpe ozali na mpasi na ntolo
and your symptoms do not go away in five days
mpe basymptomi na yo ezali kosila te nsima ya mikolo misato
and you said this is a pressure in your chest
mpe olobi oyo ezali kilo na tolo
anyone in the family have a heart problem heart disease heart attack high cholesterol high blood pressure
moto na libota azali kobela motema, motema ya kokangama tansio ya komata
any other symptoms or problems that you notice with the muscle aches?
yo omoni basymptomi misusu to mikakatano na mpasi ya misisa?
any sharp pain on your left side of your chest?
mpasi ya makasi na ntolo na esika ya loboko ya mwasi?
are there other people sick as you at home with your same symptoms?
bato misusu na ndako na yo bazali kobela na basymptomi moko oyo ya yo?
are you having any difficulty breathing now
ozali na mpasi ya kopema sikoyo
are you having any other symptoms?
yo ozali na basymptomi misusu?
are you having any shortness of breath?
ozali kokata mpema?
are you still having the chest pain
ozali kaka na mpasi na ntolo
because this is flu season
mpo oyo ezali ntango ya grippe
besides the diabetes do you have other problems or important diseases?
totie diabeti pene ozali na mikakatano misusu to bokono ya makasi?
but also we shouldn't be put aside for the heart cardiac origin chest pain
mpe esengeli te totiama mpembeni bokono ya motema oyo etumboli mpasi ya ntolo
but a more important problem now is this chest pain
kasi mokakatano ya makasi sik’oyo eza pasi na tolo
but if you have the cough
kasi soki oza na kosu-kosu
but i have difficulty breathing
kasi na pasi ya kopema
but i know lot of people cough on me
kasi nayebi bato ebele bazo kosolela nga
but we need to treat every chest pain with the utmost seriousness
kasi esengeli totala likambo ya pasi na tolo na boyoki motema pasi penza
but you're breathing all right right now right?
kasi nde sik’oyo ozo pema nayo malamu eza boye?
'cause of this chest pain i totally forgot
ntina ya pasi ya tolo na bosani mobimba na yango
'cause they're having a cough
ntina baza na kosu-kosu
does it feel like somebody squeezing your chest
eza sala lokola moto azo fina yo nakati ya tolo nayo
do still feel like shortness of breath
ezo monana kaka lokola pema mokuse
do they complain of being sick similar symptoms?
bazo lela kobela na basymptomi ya ndenge moko?
do you have any blood pressure problem as far as you know?
ozali na pasi ya tension ya makila na ndenge oyebeli?
do you have any other chronic like high blood pressure or anything like that?
oza na kobela mosusu ya chroniki lokola tension ya makila to eloko ya ndenge wana?
do you have any other diseases chronic medical problems like diabetes?
oza na mabela mosusu ya chroniki pona monganga lokola mokakatano ya diabeti?
do you have any shortness of breath with that chest pain?
oza na boyoki pema mokusa elongo na pasi wana ya tolo?
do you have high blood pressure?
oza na tension ya makila emata?
do you have some shortness of breath goes with that?
oza na pema kamwa mokuse elongo na oyo wana?
do you know what symptoms she was having?
oyebi basymptomi ya ndenge nini azalaki na yango?
do your relatives have the same symptoms
bandeko nayo ya libota baza na basymptmi ya boye
do you see the image?
ozo mona elili ?
drink plenty of fluids today
mela biloko ya mayi mingi lelo
have a dry cough a cold and runny nose vomiting diarrhea
kozala na kosu-kosu ekawuka, grippe, pe zolo kotanga, kosanza, pulu-pulu
however i take tests for the diabetes
kasi nde salisa tesite pona diabeti
however she has symptoms quite similar to mine
kasi nde aza basymptomi ekokani kamwa na yanga
how high is your fever?
fievre nayo emati na niveau nini ?
how' s your blood pressure?
tansion nayo ya makila eza ndenge nini?
i don't think i have high blood pressure
nakanisi te ete naza na tension ya makila
i feel a pain in the chest here in the front part of the chest
Nazo yoka pasi na kati ya tolo awa na ngambo ya liboso ya tolo
if you continue to have high fevers
soki ozo landela kaka koyoka bafievre emata
if you have a fever of a hundred and two or higher
soki ozali na fievre ya kama na mibale to likolo
if you think that your symptoms or problems warrant a better look
soki okanisi ete basymptomi nayo ekomi mikakatano ezo senga batala yango malamu
i got a fever yesterday
nazalaki na fievre lobi loleki
i got a slight fever too
naza na fievre moke lisusu
i had a fever yesterday
nazalaki na fievre lobi loleki
i had a short sharp pain in my chest
naza na pasi ya songe nakati ya tolo nanga
i have a sharp pain here in the chest
naza na pasi ya songe awa na kati ya tolo
i have hay fever though too
naza pe na fievre ya foin lisusu
i have made on the body around the chest area?
naza na pasi na nzoto na ngambo ya tolo mobimba?
i have some difficulty breathing too
naza na kamwa pasi pe pona kopema
i'll send you an image
na kotindela yo elili
i'm having some chest pain today
nazo yoka kamwa pasi na tolo mokolo ya lelo
i'm just having some headaches and some fever today
nazo yoka moto kobeta kamwa na fievre mokolo ya lelo
in my opinion it is flu
na ndenge nazo monela eza grippe
in my opinion this is a little flu
na ndenge nazo monela oyo eza grippe moke
i see it going from the center of your chest going up to your neck
nazo mona yango ozo kende banda kati-kati ya tolo nayo tii na likolo ya kingo nayo
is it like some heavy heavy person sitting on your chest?
ezo sala neti moto ya monene afandeli yo na tolo nayo?
it all started with the headaches and with the fever about the same time
nionso ebandaki na moto pasi pe na fievre elongo tango moko
it hurts in the chest
ezo swa kati ya tolo
it hurts in the middle of my chest
ezo swa na kati-kati ya tolo nanga
it is a pressure like chest pain
eza compression lokola pasi ya tolo
it is in my chest
eza nakati ya tolo nanga
it is in the center of my chest
eza na kati-kati ya tolo nanga
it is in the center of the chest
eza na kati-kati ya tolo
it is occurring right in the middle of my chest
ezo sala na butu na kati-kati ya tolo nanga
it is right in the center of my chest
eza kaka na kati-kati ya tolo nanga
it sounds like you just may have the garden variety cold or a flu
ezo yokama lokola oza kaka na malili lolenge ya grippe ya bilanga
i've got pain in my chest
nazo yoka pasi na kati ya tolo nanga
i've very concerned of this chest pain
nazo banga pona pasi ya tolo oyo
i want you to tell me in describing this chest pain
nalingi olobela nga na bolimboli pasi ya tolo yango
i will send you an image
na kotindela yo elili
i will send you an image on your screen
nakotindela ya elili moko na ecran nayo
like high blood pressure or diabetes
lokola tension ya makila emata to diabeti
like right in the center of the chest
lokola kaka nakati-kati ya tolo
most of the time it is this type of chest pain
mbala mingi ezalaka pasi ya tolo ya ndenge boye
my sister has similar symptoms
ndeko ya mwasi nanga aza na basymptomi ya boye
now for the fever you can take a tachipirina sweet
sik’oyo pona fievre oko komela tachipirina sweet
now i send you an image
sik’oyo natindeli elili
now mary how many days have you had the symptoms
sik’oyo mary mikolo boni osi yoki basymptomi yango
now you said you have a chest pain
sik’oyo olobi oza na pasi ya tolo
occasionally i have some chest pain
tango mosusu nazalaka na pasi na tolo
okay are you having any other symptoms along with this other than just the pain
namoni, bongo nde ozo yoka basymptomi mosusu elongo longola kaka pasi ya tolo
or if you have high blood pressure
to soki ozali na tension ya makila emata
or somebody sitting on your chest?
to moto afandeli yo na tolo?
pretty much the same with the fever and the cough headache and muscle pains
eza kaka ndenge moko na moto kobeta, na fievre, kosu-kosu ,na pasi ya misuni
right in the middle of my chest
kaka na kati-kati ya tolo nanga
show me on this image where you feel the pain
lakisa nga na elili oyo esika nini ozo yokela pasi
since you have a fever
lokola ozali na fievre
so do you think that some of these symptoms could be related to being pregnant?
boye okanisi basymptomi mike-mike mosusu eko kozala mpo oza na zemi?
so your chest pain started this morning
boye nde pasi nayo ya tolo ebandaki lelo na tongo
so your children are having some of the same symptoms?
boye bana nayo baa na basymptomi mike-mike lokola yayo?
tell me about your chest pain
lobela nga pasi ya tolo nayo
the fever increases at night
fievre ekomaka makasi na butu
the fever i've had for the last two days
fievre oyo nazalaki na yango mikolo mibale oyo eleki
the fever started to increase last night
fievre ebandaki kokoma makasi butu eleki
the fever started two days ago
fievre ebandaki mikolo mibale eleki
the muscle pains with the hay fever
pasi ya misuni na fievre ya foin
this is doctor porter in the emergency room triage center
awa dokutele porter na triage ya centre ya urgence
well can you tell me a little bit more about your chest pain?
malamu, oko koyebisa nga kamwa mingi ya pasi ya tolo nayo?
well from my point of view it is a little flu
bo, na ndenge nazo monela eza kamwa grippe moke
well i feel a pain in the front of my body here in my chest
bo, nazo yoko pasi liboso ya nzoto nanga awa nakati ya tolo nanga
well i've been having a strong pain in my chest
bo, nazo yoka pasi ya makasi na kati ya tolo nanga
well madam from listening to your symptoms it sounds like you've got one of the flu viruses
bo, mama na ndenge nazo yokela basymptomi nayo eza lokola oza na moko ya bavirus
well when i have that pain in my chest
bo, tango nazalaka na pasi wana na kati tolo nanga
what kinda pain do you have in your chest?
pasi ya ndenge nini oza na yango na tolo nayo?
when this chest pain started?
tango pasi yango ya tolo ebandaki ?
where do you have the pain in the chest?
esika nini ozo yokela pasi yango kati ya tolo?
where you feel this chest pain eel this chest t
esika nini ozo yokela pasi yango ya tolo na tolo yango
you are probably having chest pain
emonani lokola oza na pasi katiya tolo
you feel like tightness on your chest
ozo yoka lokola tolo nayo ezo kangama
you know i got diabetes and stuff
oyebi naza na diabeti na biloko mosusu
you said you're having this chest pain
olobaki ozo yoka pasi yango ya tolo
Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020
Motango ya bato oyo bazobela maladi ya coronavirisi (COVID-19) ezokoma mingi noki na mikili ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni, banda mokolo ya 1 sanza ya yambo kino mokolo ya 15 sanza ya misato 2020
The cumulative incidence of coronavirus disease (COVID-19) cases is showing similar trends in European Union/European Economic Area countries and the United Kingdom confirming that, while at a different stage depending on the country, the COVID-19 pandemic is progressing rapidly in all countries.
Soki totali bato nyonso oyo bazobela maladi ya coronavirisi (COVID-19) bazomonisa bilembo ya ndenge moko na mikili ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni, yango ezondimisa ete, ata eza na banivo ekeseni na kotalela mokili mokomoko, maladi ya COVID-19 ezopanzana noki na mikili nyonso.
Based on the experience from Italy, countries, hospitals and intensive care units should increase their preparedness for a surge of patients with COVID-19 who will require healthcare, and in particular intensive care.
Na kotalela makambo oyo esalemi na Italie, mikili, balopitalo mpe bisika ya soins intensifs basengeli mpenza kobongama mpo na koyamba bato mingi ya maladi ya COVID-19 oyo ekosenga ete basalisa bango, mingimingi na soins intensifs.
On 31 December 2019, a cluster of pneumonia cases of unknown aetiology was reported in Wuhan, Hubei Province, China.
Na mokolo ya 31 sanza ya zomi na mibale 2019, bakangaki bato mingi na maladi ya mpema oyo eyebani te na mboka Wuhan, na etuka ya Hubei, na Chine.
On 9 January 2020, the China Center for Disease Control and Prevention reported the causative agent as being a novel coronavirus now referred to as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Na mokolo ya 9 sanza ya yambo 2020, Centre ya Chine oyo ebundisaka mpe ebatelaka maladi elobaki ete maladi yango eutaki na lolenge ya sika ya coronavirisi oyo babengi sikoyo maladi ya makasi ya mpema coronavirisi 2 (SARS-CoV-2).
Since, the illness resulting from SARS-CoV-2 infection has been named coronavirus disease (COVID-19).
Banda wana, bazobenga maladi oyo eutaka na SARS-CoV-2 ete maladi ya coronavirisi (COVID-19).
Evidence to date is that ca 80% of individuals with COVID-19 have a mild disease, i.e. a respiratory tract infection with or without pneumonia, and most of these recover.
Bilembeteli tozali na yango lelo emonisi ete bato 80% oyo baza na COVID-19 baza na maladi ya mwa moke, ndakisa maladi ya mpema elongo to kozanga mpasi ya kopema, mpe mingi na bango bazobika.
In ca 14% cases, COVID-19 develops into a more severe disease requiring hospitalisation while the remaining 6% cases experience critical illness requiring intensive care.
Na bato 14%, COVID-19 ezouta na maladi makasi oyo ezosenga bakota lopitalo, ebongo bato 6% bazobela maladi makasi mpenza mpe ezosenga bazala na soins intensifs.
The mortality of patients hospitalised due to COVID-19 is ca 4%.
Motango ya bato bakoti lopitalo mpo na COVID-19 oyo bazokufa eza 4%.
In this study, we assess the trends in the cumulative incidence of COVID-19 in each European Union/European Economic Area (EU/EEA) country and the United Kingdom (UK) and compare them to that of Hubei Province, China.
Na bolukiluki oyo, tozotala ndenge makambo ezosalema na makambo nyonso ya COVID-19 na mokili mokomoko ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni (UK) mpe tozokokokanisa yango na oyo ya etuka ya Hubei, na Chine.
We also compare the current number of COVID-19 cases in EU/EEA countries and the UK with that in Italy during 31 January–15 March 2020.
Tozokokanisa mpe motango ya sikoyo ya bato bazobela COVID-19 na mikili ya Eropa/Esika ya Nkita ya Eropa pe na Royaume-Uni na oyo ya Italie banda na mokolo ya 31 sanza ya yambo kino na mokolo ya 15 sanza ya misato 2020.
COVID-19 cases in EU/EEA countries and the UK
Bato bazobela COVID-19 na mikili ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni
Subsequent to China, COVID-19 underwent further geographical spread and the dynamic of the COVID-19 pandemic in the rest of the world currently follows that of this country.
Ndenge esalemaki na Chine, COVID-19 epanzanaki na bamboka mosusu mpe maladi wana ya COVID-19 ezopanzana ndenge moko na mikili mosusu kaka ndenge esalemaki mboka wana.
On 11 March 2020, the Director General of the World Health Organization (WHO) declared COVID-19 a pandemic.
Na mokolo ya 11 sanza ya misato 2020, diretere ya organisation mondiale de la santé (OMS) alobaki ete COVID-19 eza maladi mabe.
In the 5 March issue of Eurosurveillance 2020, Spiteri et al. reported on the first European confirmed COVID-19 cases according to the WHO case definition.
Na mokolo ya 5 sanza ya misato likambo ya Eurosurveillance 2020, Spiteri mpe baninga na ye, elobelaki bato ya Eropa ya liboso oyo babeli COVID-19 na kotalela ndimbola oyo OMS ezopesa.
In the EU/EEA, the first three confirmed cases were reported by France on 24 January 2020 in persons returning from Wuhan, Hubei Province, China.
Na mikili ya Eropa/Esika ya Nkita ya Eropa, bato misato ya liboso oyo bazwaki maladi elobamaki na France na mokolo ya 24 sanza ya yambo 2020; eza bato oyo bautaki na Wuhan, na etuka ya Hubei, na Chine mpe bazongaki na France.
As at 15 March 2020, COVID-19 cases had been detected in all 30 EU/EEA countries and the United Kingdom (UK), whereby between 31 December 2019 and that date included, 39,768 cases and 1,727 deaths had been reported, with 17,750 cases and 1,441 deaths from Italy alone.
Na mokolo ya 15 sanza ya misato 2020, bato bazalaki kobela maladi ya COVID-19 na mikili nyonso 30 ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni (UK), mpe banda mokolo ya 31 sanza ya zomi na mibale 2019 mpe kotanga dati wana, bato 39 768 babeli yango mpe bato 1 727 bakufaki na maladi wana mpe na Italie mpamba bato 17 750 bazwaki yango kasi bato 1 441 bakufaki.
Obtaining cumulative number and cumulative incidence of COVID-19 cases
Kozwa motango nyonso mpe bato nyonso oyo bazwi COVID-19
At the European Centre for Disease Prevention and Control (ECDC), the notified COVID-19 case counts in each country worldwide, obtained from only official sources such as the countries’ Ministry of Health, national and regional health authorities and the WHO, are updated each day at 8:00 a.m.
Na centre ya Eropa oyo ebundisaka mpe ebatelaka maladi (ECDC), motango ya bato ya COVID-19 na mokili mokomoko, oyo bazwaka kaka na ba source officiel na ndakisa ministere ya santé ya mikili nyonso, bakonzi ya santé ya mokili mpe ya etuka mpe na OMS, etyamaka ya sika mokolo nyonso na 8H00 na ntongo.
These data were used for assessing the trends of COVID-19 in EU/EEA and the UK, and comparing them to that in Italy.
Basalelaki bansango wana mpo na koyeba ndenge COVID-19 ezopanzana na mikili ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni, mpe bakokanisaka yango na ya Italie.
As a proxy of the prevalence of active COVID-19 cases, we calculated the 14-day truncated cumulative incidence of COVID-19 cases, thus taking into account the natural course of COVID-19, in each EU/EEA country and the UK, during the 1 January–15 March 2020 period.
Na oyo etali ndenge bato oyo baza mpenza na maladi ya COVID-19, totalelaka mikolo 14 oyo yango ekomaka makasi mpo na bato ya COVID-19, yango wana totalelaka ndenge COVID-19 ekolaka, na mokili mokomoko ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni, na eleko ebandi na 1 sanza ya liboso kino 15 sanza ya misato 2020.
We also presented the cumulative number of notified cases of each country as at 15 March 2020 8:00 a.m. compared with that of Italy for the 31 January–15 March 2020 period.
Topesaki mpe motango nyonso ya bato ya maladi na mokili mokomoko na mokolo ya 15 sanza ya misato 2020 na 8H00 na ntongo, tokokanisaki yango na motango ya Italie banda na mokolo ya 31 sanza ya yambo kino na mokolo ya 15 sanza ya misato 2020.
Trends of COVID-19 in EU/EEA countries and the UK
Ndenge bato bazobela COVID-19 na mikili ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni
The trends in the 14-day truncated cumulative incidence of COVID-19 cases in EU/EEA countries and the UK generally followed that of Hubei Province (China) (Figure 1).
Ndenge bato bazokolisa maladi COVID-19 na mikolo 14 na mikili ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni ezolanda ndenge esalemaki na etuka ya Hubei (Chine) (Motango1).
For the EU/EEA and the UK overall, the cumulative incidence of COVID-19 started to increase around 21 February and then increased sharply around 28 February 2020 (Supplementary material).
Mpo na mikili ya Eropa/Esika ya Nkita ya Eropa mpe Royaume-Uni, maladi ya COVID-19 ebandaki kokoma mingi pene ya mokolo ya 21 sanza ya mibale mpe na nsima ekomaki mwa mingi pene ya mokolo ya 28 sanza ya mibale 2020 (Bansango mosusu).
This was mostly driven by the rapid increase in the number of reported cases from Italy, but all other EU/EEA countries and the UK showed similar increasing trends of the cumulative incidence of COVID-19 (Supplementary material).
Esimbamaki mingi na motango ya bato mingi oyo bazalaki kozwa maladi yango na Italie, kasi na mikili nyonso ya Eropa/Esika ya Nkita ya Eropa motango ya bato ya maladi COVID-19 ezalaki mpe komata ndenge moko (Bansango mosusu).
Figure 2 shows the cumulative number of COVID-19 cases, in EU/EEA countries and the UK compared with that in Italy for the 31 January–15 March 2020 period.
Motango 2 ezomonisa motango nyonso ya bato bazobela COVID-19, na mikili ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni soki tokokanisi yango na oyo ya Italie banda na mokolo ya 31 sanza ya yambo kino na mokolo ya 15 sanza ya misato 2020.
It highlights that, as at 15 March 8:00 a.m., 15 other EU/EEA countries and the UK had already reported a total number of cases comparable to that of Italy just 3 weeks prior or less.
Ezomonisa ete, na mokolo ya 15 sanza ya misato na 8H00 na ntongo, mikili 15 mosusu ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni ezalaki na motango ya bato ya maladi wana ndenge moko na Italie kaka mwa bamposo 3 to moke liboso.
Our results indicate that the number of notified cases of COVID-19 is rapidly increasing in the EU/EEA and the UK.
Ba résultat na biso ezolakisa ete motango bato oyo bazwi COVID-19 ezomata makasi na mikili ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni.
The observed trends in the cumulative incidence of COVID-19 suggest that the pandemic is progressing at a comparable speed in all countries.
Makambo tomoni na bato nyonso bazobela COVID-19 ezolakisa ete maladi mabe ezopanzana ndenge moko na mikili misusu.
This is despite countries being at different stages, variations in national public health responses, and possibly different case definitions in countries and different protocols for selecting patients that must be tested for confirmation of COVID-19, including catch-up testing.
Eza bongo ata mikili eza na banivo ekeseni, bato oyo basalaka mosala ya monganga bazosunga bato ndenge moko te, mpe mbala mosusu kolimbola maladi na ndenge mosusu na mikili mpe mibeko ekeseni mpo na kopona bato ya maladi oyo basengeli kosalisa ekzame mpo na koyeba soki baza na COVID-19, ata mpe kosala ekzame na nsima.
Early March 2020, doctors in the affected regions of Italy described a situation in which ca 10% of patients with COVID-19 required intensive care and media sources reported that hospitals and intensive care units in these regions had already reached their maximum capacity.
Na ebandeli ya sanza ya misato 2020, minganga ya Italie bisika maladi ezalaki, balobaki ete bato ya maladi 10% oyo baza na COVID-19 baza na mposa ya soins intensifs mpe bapanzi-nsango balobaki ete soins intensifs ya balopitalo ya bituka wana etondaki koleka ndelo.
Data on admission of COVID-19 cases in a hospital and/or an intensive care unit are currently available at EU/EEA level for only 6% and 1% cases, respectively (data not shown).
Bansango ya bato ya COVID-19 oyo bakotaki lopitalo mpe/to na soins intensifs eza sikoyo na mikili ya Eropa/Esika ya Nkita ya Eropa mpo na bato 6% mpamba mpe 1%, (bansango elakisami te).
They should, however, be collected in a systematic fashion to complement current surveillance data that focus on the number of reported cases and the number of deaths.
Kasi, basengeli kosangisa yango malamumalamu mpo na kobakisa yango na bansango ya sika oyo ezolobeli mingi motango ya bato oyo baza na maladi mpe motango ya baoyo bakufi.
A study performed in 2010–11 showed a large variation in the availability of intensive care and intermediate care beds in Europe, ranging from 29.2 in Germany to 4.2 beds per 100,000 population in Portugal.
Bolukiluki moko oyo esalemaki na 2010–11 emonisaki mbongwana monene na soins intensifs mpe ya bambeto ya katikati na Eropa, ezalaki 29,2 na Allemagne mpe bambeto 4,2 mpo na bato 100 000 na Portugal.
This means that countries may have more or less resources than Italy (12.5 intensive care and intermediate care beds per 100,000 population in 2010–11).
Elimboli ete mikili ekoki kozala na makoki mingi to moke koleka Italie (12,5 soins intensif mpe bambeto ya katikati mpo na bato 100 000 na 2010–11).
Modelling scenarios related to healthcare capacity saturation, with estimates for each EU/EEA country and the UK of the prevalence of hospitalised COVID-19 cases associated with a &gt; 90% risk of exceeding intensive care bed capacity, are provided in the sixth update of the ECDC rapid risk assessment on COVID-19.
Kobongisa makambo ya kosalisa bato ya maladi elekeli minganga, mpo motango ya pene mpo na mokili nyonso ya Eropa/Esika ya Nkita ya Eropa mpe Royaume-Uni na kotalela bato bakoti lopitalo mpo na COVID-19 mpe mpo na a &gt; 90% ya likama ya kozanga bambeto na soins intensif, epesami na makambo ya sika ya motoba ya ECDC mpo na botaleli ya lombango ya likama ya COVID-19.
Since cases have so far clustered in certain regions in EU/EEA countries and the UK, and hospitals and intensive care units usually serve a defined regional catchment population, information about cases and intensive care beds should preferably be made available at the Nomenclature of territorial units for statistics 2 (NUTS-2) level.
Mpo bato ya maladi bakomi mingi na bisika mosusu na mikili ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni, mpe balopitalo na bisika ya soins intensifs esalelamaka mbala mingi mpo na kobomba bato ya etuka moko boye, bansango etali bamaladi mpe bambeto ya soins intensifs esengeli ezala libre na eteni ebengami Nomenclature ya biteni ya nivo ya bansango 2 (NUTS-2).
The experience from Italy and the current trends in other countries show that the COVID-19 pandemic is progressing rapidly in the EU/EEA and the UK.
Makambo esalemi na Italie mpe oyo ezosalema sikoyo na mikili mosusu emonisi ete maladi mabe ya COVID-19 ezopanzana noki na mikili ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni.
Countries, hospitals and intensive care units should thus prepare themselves for a scenario of sustained community transmission of SARS-CoV-2 and an increase in the number of patients with COVID-19 requiring healthcare, and in particular intensive care, such as the one occurring in the affected regions of Italy.
Mikili, balopitalo mpe bisika ya soins intensifs esengeli komibongisa na ndenge ya bakosala makambo soki bato mingi bazwi SARS-CoV-2 mpe soki motango ya bato oyo bazwi COVID-19 oyo bazoluka lisalisi ekomi mingi, mpe mingimingi na soins intensif, na ndakisa oyo ezosalema na bamboka ya Italie esika maladi wana ezali.
As pointed out in the recent ECDC rapid risk assessment, a rapid, proactive and comprehensive approach is essential to delay the spread of SARS-COV-2, with a shift from a containment to a mitigation approach, as the anticipated rapid increase in the number of cases may not provide decision makers and hospitals enough time to comprehend, accept and adapt their response accordingly if not implemented ahead of time.
Ndenge bamonisaki yango na botaleli ya lombango ya likama oyo esalemaki kala te na ECDC, metode ya noki, ya malamu mpe ebongi mpenza eza ntina mpo na kokanga SARS-COV-2 nzela epanzana te, kolongola likebi na bato oyo bazozwa maladi mpe kotya yango na kokitsa ntalo ya contamintaion; mpo koluka koyeba liboso ndenge bato mingi bakobela ekosalisa mpenza te bato bazwaka bikateli mpe balopitalo bakozala te na ntango ya kokanga ntina na yango, kondima yango mpe kobongama na kosunga soki bameki yango te liboso.
The rapid risk assessment also lists the public health measures to mitigate the impact of the pandemic.
Botaleli ya lombango ya likama ezolobela mpe bibongiseli ya sante ya bato mingi mpo na kolembisa bokoli ya maladi mabe.
There is a short window of opportunity during which countries have the possibility to further increase their control efforts to slow down the spread of SARS-CoV-2 and decrease the pressure on healthcare.
Eza na mwa libaku moke na ntango oyo mikili ezali na libaku ya kobakisa controle ya milende bazosala mpo na kosala ete SARS-CoV-2 epanzana mingi te mpe kokotisa pression na minganga.
Failing this, it is likely that the healthcare systems of other EU/EEA countries will face a surge of patients that require intensive care within the coming days or weeks.
Soki basali yango te, bibongiseli ya sante ya mikili mosusu ya Eropa/Esika ya Nkita ya Eropa ekozala na bato mingi lisusu oyo bakobela mpe ekosenga batya bango na soins intensifs na mikolo to na bamposo ezoya.
The outbreak of Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), has thus far killed over 3,000 people and infected over 80,000 in China and elsewhere in the world, resulting in catastrophe for humans.
Kobima ya maladi ya coronavirisi 2019 (COVID-19), oyo euti na maladi makasi ya mpéma (SARS) coronavirirsi 2 (SARS-CoV-2), esi ebomi bato koleka 3 000 mpe ezwi bato koleka 80 000 na Chine mpe na bisika mosusu na mokili mobimba, yango esali ete ekoma likama monene mpo na bato.
Similar to its homologous virus, SARS-CoV, which caused SARS in thousands of people in 2003, SARS-CoV-2 might also be transmitted from the bats and causes similar symptoms through a similar mechanism.
Na boyokani na ndeko na yango virisi, SARS-CoV, oyo esalaki bankoto ya bato babela SARS na 2003, ekoki kozala ete SARS-CoV-2 eutaki mpe na bangembo mpe eza na bilembo ya ndenge moko mpe ekotaka na ndenge moko.
However, COVID-19 has lower severity and mortality than SARS but is much more transmissive and affects more elderly individuals than youth and more men than women.
Atako bongo, COVID-19 eza makasi mingi te mpe ezoboma bato mingi te lokola SARS kasi ezopanzana na bato mingi mpe ezonyokola mingi mibange koleka bilenge mpe ezozwa mingi mibali koleka basi.
In response to the rapidly increasing number of publications on the emerging disease, this article attempts to provide a timely and comprehensive review of the swiftly developing research subject.
Ndenge mikanda oyo ezolobela maladi yango ezokoba kokoma mingi, mokano ya lisolo oyo eza ya kopesa bansango eyei na ntango malamu mpe na kolobela misala ya bolukiluki oyo ezosalema na likambo oyo.
We will cover the basics about the epidemiology, etiology, virology, diagnosis, treatment, prognosis, and prevention of the disease.
Tokolobela makambo ya ntina na oyo etali epidemiologie, etiologie, virologie, ndenge ya koyeba yango, ndenge ya kobikisa, pronostique, mpe libateli na maladi yango.
Although many questions still require answers, we hope that this review helps in the understanding and eradication of the threatening disease.
Ata soki mituna mingi eza nanu te na biyano, tokanisi ete lisolo oyo ekosalisa yo na koyeba mpe kosilisa maladi oyo ya mabe.
The Spring Festival on January 25, 2020 has become an unprecedented and unforgettable memory to all Chinese who were urged to stay indoors for all the holiday and for many weeks after due to the outbreak of a novel viral disease.
Fete ya printemps ya mokolo ya 25 sanza ya yambo 2020 ekomi oyo ekokani na moko te mpe oyo bato nyonso ya Chine bakobosana te, mpo bayebisaki bango babima libanda te na fete mobimba mpe na eleko ya bamposo mingi nsima mpo na kobima ya maladi moko ya sika ya makasi.
The virus is highly homologous to the coronavirus (CoV) that caused an outbreak of severe acute respiratory syndrome (SARS) in 2003; thus, it was named SARS-CoV-2 by the World Health Organization (WHO) on February 11, 2020, and the associated disease was named CoV Disease-19 (COVID-19).
Virisi yango ekokani mingi na coronavirisi (CoV) oyo ezalaki maladi ya makasi ya mpema (SARS) na 2003; ebongo babengaki yango SARS-CoV-2 na organisation mondiale de la sante (OMS) na mokolo ya 11 sanza ya mibale 2020, mpe maladi oyo yango ebimisi babengi yango CoV Maladi-19 (COVID-19).
The epidemic started in Wuhan, China, and quickly spread throughout the entire country and to near 50 others all over the world.
Maladi yango mabe ebandaki na mboka Wuhan, na Chine, mpe epanzanaki noki na Chine mobimba mpe na pene ya mikili 50 na mokili mobimba.
As of March 2, 2020, the virus has resulted in over 80,000 confirmed cases of COVID-19, with more than 40,000 patients discharged and over 3,000 patients who died.
Na mokolo ya 2 sanza ya misato 2020, virisi wana esalaki ete bato koleka 80 000 babela COVID-19, ebongo bato koleka 40 000 babikaki mpe babimiaki na lopitalo kasi bato koleka 3 000 bakufaki.
WHO warns that COVID-19 is “public enemy number 1” and potentially more powerful than terrorism.
OMS akebisi ete COVID-19 eza “monguna ya nimero 1 ya bato” mpe ekoki kozala makasi koleka terorizme.
According to PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), in less than two months, over 200 papers have been published on COVID-19 including its virology, epidemiology, etiology, diagnosis, and treatment since the first report on January 7, 2020 that determined the sequence of the virus isolated from multiple patients.
Na kotalela PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), na nse ya sanza mibale, bato basi babimisaki masolo koleka 200 oyo ezolobela COVID-19 ata mpe virologie, epidemiologie, etiologie, ndenge ya koyeba yango, mpe ndenge ya kosalisa yango, banda basalaki rapore ya liboso na mokolo ya 7 sanza ya yambo 2020 oyo ezolimbola ndenge virisi ezopanzana na bato mingi.
This review attempts to summarize the research progress in the new and swiftly developing subject area.
Lisolo oyo ezomeka kolobela na mokuse bolukiluki oyo ezosalema na likambo oyo ya sika oyo ezopanzana noki.
Whenever possible, we will try to compare COVID-19 with SARS and another CoV-caused disease, Middle East respiratory syndrome (MERS, an outbreak in 2012).
Soki likoki ezali, tokomeka kokokanisa COVID-19 na SARS mpe maladi mosusu oyo eutaki na CoV, maladi ya mpema ya moyen-orient (MERS, oyo ebimaki na 2012).
We will also discuss what we have learned so far regarding the prevention and prognosis of the disease as well as some remaining yet urgent questions.
Tokolobela mpe makambo oyo tosi toyekoli na oyo etali kobundisa mpe pronostique ya maladi wana mpe mituna mosusu ya ntina mingi.
CoVs have been traditionally considered nonlethal pathogens to humans, mainly causing approximately 15% of common colds 4.
Bato balobaka ete CoVs eza mpenza te maladi oyo ebomaka bato, mingimingi esalaka ete bato 15% bayoka malili 4.
However, in this century, we have encountered highly pathogenic human CoVs twice, i.e., SARS-CoV and MERS-CoV, which caused an outbreak originally in China in 2003 and Saudi Arabia in 2012, respectively, and soon spread to many other countries with horrible morbidity and mortality.
Kasi, na siekle oyo, tosi tokutani na bavirisi CoVs oyo ebelisaka bato mbala mibale, na ndakisa, SARS-CoV mpe MERS-CoV, oyo ebimisaki maladi oyo eutaki na Chine na 2003 mpe na Arabie Saudite na 2012, mpe epanzanaki noki na mikili mosusu mpe ezalaki kozwa bato mingi mpe koboma bato ebele mpenza.
Therefore, the current COVID-19 is the third CoV outbreak in the recorded history of humans.
Yango wana, COVID-19 ya sikoyo eza CoV ya misato oyo ebima na lisolo ya bomoi ya bato.
As shown in Fig. ​Fig.1,1, clusters of pneumonia that had unknown origins were first reported from Wuhan on December 31, 2019 to the China National Health Commission.
Ndenge bamonisi yango na motango. ​Motango 1,1, liboke ya maladi ya mpema oyo esika euta eyebani te elobelamaki na mbala ya liboso na Wuhan na mokolo ya 31 sanza ya mibale 2019 na lisanga ya Chine oyo etalaka makambo ya kolongono ya nzoto.
Seven days later the sequence of the CoV was released.
Mikolo nsambo na nsima babimisaki ndenge CoV ebandaka.
On January 15, 2020 the first fatal case from Wuhan was reported.
Na mokolo ya 15 sanza ya yambo 2020 moto ya liboso akufaki na Wuhan.
Meanwhile, the epidemic rapidly spread to the neighboring cities, provinces, and countries.
Na ntango wana, maladi yango ezalaki kopanzana noki na bingumba, na bituka mpe na mikili ya pene.
On January 20, the infection of health-care providers was reported, suggesting that human-to-human transmission was possible.
Na mokolo ya 20, balobaki ete minganga bazwi maladi yango, yango emonisaki ete moto akoki kopesa yango na moto mosusu.
On January 23, the city of Wuhan was locked down with all its public transportation stopped.
Na mokolo ya 23 sanza ya yambo, bakangaki engumba Wuhan mpe transpore ya bato nyonso ezalaki kosala lisusu te.
On January 24 the first clinical study on the disease reported that, out of 41 patients with confirmed cases, only 21 had direct contact with the Wuhan seafood market that was considered the starting site of the infection from an unknown animal source.
Na mokolo ya 24 sanza ya yambo, babandaki kosala bolukiluki ya maladi wana, na kati ya bato 41 oyo bazalaki kobela yango, bato 21 mpamba bakomaki na zando ya mbisi ya mbu ya Wuhan esika oyo maladi yango ebandaki na nyama moko oyo eyebani te.
On January 30, WHO declared the outbreak a global health emergency.
Na mokolo ya 30 sanza ya yambo, OMS elobaki ete maladi wana eza likama mpo na mokili mobimba.
By the time of this report, the disease has already spread throughout China and near 50 other countries all over the world (Fig. ​(Fig.2).2).
Na ntango tozosala rapore oyo, maladi yango esi epanzani na Chine mobimba mpe na mikili misusu pene ya 50 na mokili mobimba (Motango. ​(Motango.2).2).
As the situation is rapidly evolving, the final scope and severity of the outbreak remain to be determined.
Ndenge makambo ezondongwana noki, bonene na yango ya nsuka mpe makasi na yango eyebani nanu te.
On February 11, 2020, a multi-center study on 8,866 patients including 4,021 confirmed COVID-19 patients presented a more updated illustration of the epidemic as follows (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
Na mokolo ya 11 sanza ya mibale 2020, bolukiluki na bato ya maladi 8 866 tanga mpe bato 4 021 oyo bazalaki mpenza na COVID-19 emonisaki makambo ya sika na ntina na maladi mabe ndenge eza na nse (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 infected people of all ages, but mainly at the age of 30-65.
SARS-CoV-2 ezozwa bato ya mbula nyonso, kasi mingimingi bato ya mbula 30-65.
Almost half (47.7%) of the infected individuals were over 50 years old, very few were under 20, and only 14 infected individuals were under the age of 10.
Pene ya katikati (47,7%) ya bato oyo babelaki baza na mbula koleka 50, moke mpenza baza na mbula na nse ya 20, mpe bato 14 mpamba ya maladi bazalaki na mbula na nse ya 10.
SARS-CoV-2 infected more men (0.31/100,000) than women (0.27/100,000).
SARS-CoV-2 ezwaki mingi mibali (0,31/100 000) koleka basi(0,27/100 000).
COVID-19 expanded in clusters mainly in and around Hubei.
COVID-19 epanzanaki na bituluku mingimingi na Hubei mpe pene na yango.
COVID-19 took an average of 5 (2-9) days from onset to diagnosis.
COVID-19 ezwaki na mwayene mikolo 5 (2-9) banda ebandeli kino mokolo bamonaki yango.
The average incubation period was 4.8 (3.0-7.2) days.
Mwayene ya mikolo oyo maladi esalaka liboso emonana eza mikolo 4,8 (3,0-7,2).
The average time from onset to death was 9.5 (4.8-13) days.
Mwayene ya mikolo banda ebandeli na yango kino liwa eza mikolo 9,5 (4,8-13).
The basic reproductive number (R0) was 3.77 (95% CI: 3.51-4.05), and the adjusted R0 was 2.23-4.82.
Motango ya kobotisa yango (R0) eza 3,77 (95% CI: 3,51-4,05), mpe kobongwana ya R0 ezalaki 2,23-4,82.
The number of infected people increased exponentially before 23 Jan. 2020, matching the time of massive transportation before the Spring Festival in China.
Motango ya bato oyo bazwi maladi emataki mingi liboso ya mokolo ya 23 ya sanza ya yambo 2020; yango ekokani na ntango oyo bato basalelaki transpore mingi na fete ya printemps na Chine.
The mortality of patients with confirmed cases was 1.44% (95% CI: 1.10-1.86%), and the adjusted mortality of all the patients was 3.06% (95% CI: 2.02-4.59%).
Bato ya maladi oyo kokufa ezalaki 1,44% (95% CI: 1,10-1,86%), mpe kobongwana ya motango ya bato bakufaki eza 3,06% (95% CI: 2,02-4,59%).
Three major risk factors for COVID-19 were sex (male), age (≥60), and severe pneumonia.
Makambo misato ya minene ya likama ya COVID-19 ezalaki sexe (mobali), mbula (≥60), mpe mpema makasi.
CoVs are a subfamily of large and enveloped viruses containing a single strand of sense RNA.
CoVs eza na kati ya libota monene ya bvirisi mpe na kati ya bavirisi oyo eza na mwa boyokani na RNA.
They can be divided into four genera, i.e., alpha, beta, gamma, and delta, of which alpha- and beta-CoVs are known to infect humans.
Tokoki kokabola yango na biteni minei, na ndakisa., alpha, beta, gamma, mpe delta, ebongo alpha- na beta-CoVs eyebani ete ezwaka bato.
The envelope spike (S) glycoprotein binds to its cellular receptors angiotensin-converting enzyme 2 (ACE2) and dipeptidyl peptidase 4 (DPP4) for SARS-CoV and MERS-CoV, respectively, and then membrane fusion occurs.
Nsonge ya (S) glycoproteine ekangamaka na ba recepteur na yango ya angiotensine mpe ebongalaka enzyme 2 (ACE2) mpe dipeptidyl peptidase 4 (DPP4) mpo na SARS-CoV mpe MERS-CoV, mpe na nsima membrane esanganaka.
The viral RNA genome is released into the cytoplasm; after replication of the viral genome, genomic RNA accompanied by envelope glycoproteins and nucleocapsid proteins forms virion-containing vesicles, which then fuse with the plasma membrane to release the virus.
Virisi RNA ebimaka na cytoplasme; nsima ya kopanzana ya virisi wana, virisi RNA eyaka na kati ya anvelope ya glycoproteine mpe baproteine nucleocapside esalaka vesicule oyo eza na virion, oyo esanganaka na plazma mpo na kobimisa virisi.
The first genomic sequence of SARS-CoV-2 was reported on January 10, 2020.
Genome ya liboso ya SARS-CoV-2 emonanaki na mokolo ya 10 sanza ya yambo 2020.
SARS-CoV-2 was found to be a new type of beta-CoV with more than 99.98% genetic identity among 10 sequenced samples collected from the original site of the outbreak, the Huanan Seafood Market in Wuhan.
Bamonaki ete SARS-CoV-2 ezalaki lolenge ya sika ya beta-CoV oyo ezalaki na na identité 99,98% ya makila na kati ya bandakisa 10 oyo bazwaki na esika oyo yango ebimaki na mbala ya liboso, na zando Huanan ya koteka banyama ya mbu na Wuhan.
SARS-CoV-2 is genetically more similar to SARS-CoV than to MERS-CoV.
SARS-CoV-2 ekokani mpenza na SARS-CoV kasi na MERS-CoV te.
Through transmission electron microscopy, SARS-CoV-2 particles were found in ultrathin sections of human airway epithelium.
Na nzela ya kopanzana ya electron ya mikroskope, biteni ya SARS-CoV-2 emonanaka na nzoto ya bato na nzela ya kopema.
Human ACE2 was found to be a receptor for SARS-CoV-2 as well as SARS-CoV.
Bamonaki ete ACE2 ya bato ezalaki eloko ezwaka SARS-CoV-2 mpe SARS-CoV.
However, the S protein of SARS-CoV-2 binds to human ACE2 more weakly than that of SARS-CoV, which is coincident with the fact that SARS-CoV-2 causes less severe infection in patients than SARS-CoV.
Kasi, proteine S ya SARS-CoV-2 ekangami makasi te na ACE2 ya bato koleka ya SARS-CoV, oyo eyokani na likambo oyo ete SARS-CoV-2 ezopesa bato maladi ya makasi te lokola SARS-CoV.
SARS-CoV-2 can also form a novel short protein encoded by orf3b and a secreted protein encoded by orf8.
SARS-CoV-2 ekoki mpe kosala proteine ya moke ya sika oyo euti na orf3b mpe ebimisaka proteine euti na orf8.
The orf3b of SARS-CoV-2 may play a role in the viral pathogenicity and inhibit the expression of IFNβ; however, orf8 does not contain any known functional domain or motif.
Lolenge orf3b ya SARS-CoV-2 ekoki kozala na mokumba makasi na kobima ya virisi wana mpe komonisa bilembo ya IFNβ; kasi, orf8 ezalaka te na mosala to motif oyo eyebana.
On February 18, 2020, Zhou, et al., reported the cryo-EM structure of the full-length human ACE2 at 2.9 Å resolution in complex with the amino acid transporter B0AT1.
Na mokolo ya 18 sanza ya mibale 2020, Zhou, mpe baninga, elobelaki nzoto ya cryo-EM ya ACE2 ya bato ya molai mpenza na 2,9 Å ya mindondo ezalaki na eloko ememaka aside amino B0AT1.
They found that the complex, which had open and closed conformations, was assembled as a dimer and the ACE2-B0AT1 complex can bind two S proteins, which provides evidence for CoV recognition and infection.
Bamonaki ete mindondo wana, oyo ezalaki kofungwama mpe kokangama, esangisamaki esika moko mpe ACE2-B0AT1 ya mindondo ekoki kosangisa baproteine S mibale, oyo ezopesa bilembeteli ya koyeba CoV mpe maladi wana.
B0AT1 may become a therapeutic target for drug screening to suppress SARS-CoV-2 infection.
B0AT1 ekoki kokoma eloko ya kosalela bankisi mpo na kosilisa maladi ya SARS-CoV-2.
The origin and intermediate host
Esika eutaka mpe esika ya mibale oyo efandaka
It has been known that both SARS-CoV and MERS-CoV originated from bats and were transmitted to humans via civet cats and camels, respectively.
Eyebani ete SARS-CoV mpe MERS-CoV eutaki na bangembo mpe epesamaki na bato na nzela ya banyau civet mpe bakamela.
Through a phylogenetic comparison of SARS-CoV-2 with other CoVs, bats were considered the native host of SARS-CoV-2 as the new virus is 96% identical to two SARS-like CoVs from bats called bat-SL-CoVZX45 and bat-SL-CoVZX21.
Soki tosali bokokanisi na kati ya SARS-CoV-2 na ba CoVs mosusu, bangembo nde bato bazalaki na SARS-CoV-2 mpo virisi oyo ya sika ekokani na 96% na bavirisi CoVs oyo ekokokani na ba SARS mibale oyo eutaki na bangembo oyo babengaka bat-SL-CoVZX45 mpe bat-SL-CoVZX21.
However, what intermediate host helped the virus cross the species barrier to infect humans remains unknown, and the transmission route is yet to be elucidated.
Kasi, eloko oyo esalisaki virisi na kolongwa na banyama mpo eya kokota na bato eyebani nanu te, mpe toyebi nanu te ekotaki na nzela nini.
Ji, et al., proposed snakes as a carrier of the virus from bats to humans which involved homologous recombination within the S protein.
Ji, mpe baninga na ye, balobaki ete banyoka nde ememaki virisi wana uta na bangembo mpe ekotisaki yango na bato; mpe esanganaki na kati ya proteine S.
According to a study, researchers in Guangzhou, China, suggested that pangolins - long-snouted, ant-eating mammals often used in traditional Chinese medicine - are the potential intermediate host of SARS-CoV-2 based on 99% genetic homology in a CoV discovered in pangolins and SARS-CoV-2.
Na kotalela bolukiluki moko, balukiluki esalemaki na Guangzhou, na Chine, balobaki ete bapangolin - oyo ezali banyama ebengami mamifere oyo basalelaka mbala mingi lokola bankisi ya bokoko na Chine - eza oyo mbala mosusu esika ya mibale oyo SARS-CoV-2 efandaka na kotalela 99% ya makila ya ndenge moko na CoV oyo bamonaki na bapangolin mpe na SARS-CoV-2.
However, 1% difference spread all over two genomes is still a big difference; thus, conclusive results for concrete evidence are awaited (Fig. ​(Fig.33).
Kasi, bokeseni ya 1% etaleli bavirisi mibale eza kaka bokeseni monene; yango wana, tozokoba kozela bosukisi ya solosolo (Mot. ​(Mot.33).
The physicochemical properties of SARS-CoV-2 are largely not yet known.
Makambo ya physique mpe ya chimie ya SARS-CoV-2 eyebani nanu ata moke te.
SARS-CoV and MERS-CoV can survive in vitro for 48 hours in a dry environment and up to 5 days under 20 °C and 40%-50% humidity.
SARS-CoV mpe MERS-CoV ekoki kozala na bomoi na libanda ya esika oyo bazalaka na bomoi na bangonga 48 na esika ya kokauka mpe kino na mikolo 5 na nse ya 20 °C mpe na 40%-50% na esika ya malili.
SARS-CoV-2 may possess similar properties.
SARS-CoV-2 ekoki kozala na bizaleli ya ndenge moko.